(Q39169346)

English

Biochemical modulation of 5-fluorouacil through dihydropyrimidine dehydrogenase inhibition: a Southwest Oncology Group phase II trial of eniluracil and 5-fluorouracil in advanced resistant colorectal cancer

scientific article published on November 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Biochemical modulation of 5-fluorouacil through dihydropyrimidine dehydrogenase inhibition: a Southwest Oncology Group phase II trial of eniluracil and 5-fluorouracil in advanced resistant colorectal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

phase II clinical trial

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

object named as

Southwest Oncology Group

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

author name string

Cynthia G Leichman

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Kari Chansky

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

John S Macdonald

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Michael A Doukas

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

G Thomas Budd

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Jeffrey K Giguere

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

James L Abbruzzese

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

419-424

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12448660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12448660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12448660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12448660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile

1 reference

https://pubmed.ncbi.nlm.nih.gov/12448660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-Ethynyluracil (776C85): modulation of 5-fluorouracil efficacy and therapeutic index in rats bearing advanced colorectal carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12448660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12448660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12448660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase

1 reference

https://pubmed.ncbi.nlm.nih.gov/12448660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12448660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12448660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/12448660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1020662113061

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39169346&oldid=2202640760"